1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Samples: new trials by email Literature Review of Samples trials Research Report on Samples
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma Carillizumab, Esophagectomy, Samples - Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy | Phase 2 | Active not recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 42 | 2020-11-23 | 2026-10-02 |
Esophageal Squamous Cell Carcinoma (1)
Second Affiliated Hospital, Zhejiang University, School of Medicine (1)
China (1)
Weilin Wang (1)